Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic Cancer

Por Kunzmann, Volker, Herrmann, Ken, Bluemel, Christina, Kapp, Markus, Hartlapp, Ingo, Steger, Ulrich
Publicado em 2014

(68)Gallium- and (90)Yttrium-/(177)Lutetium: “theranostic twins” for diagnosis and treatment of NETs

Por Werner, Rudolf A., Bluemel, Christina, Allen-Auerbach, Martin S., Higuchi, Takahiro, Herrmann, Ken
Publicado no Ann Nucl Med (2014)

A case report of a solitary pancreatic metastasis of an adrenocortical carcinoma

Por Baur, Johannes, Schedelbeck, Ulla, Pulzer, Alina, Bluemel, Christina, Wild, Vanessa, Fassnacht, Martin, Steger, U.
Publicado no BMC Surg (2015)

DNA damage in blood lymphocytes in patients after (177)Lu peptide receptor radionuclide therapy

Por Eberlein, Uta, Nowak, Carina, Bluemel, Christina, Buck, Andreas Konrad, Werner, Rudolf Alexander, Scherthan, Harry, Lassmann, Michael
Publicado no Eur J Nucl Med Mol Imaging (2015)

Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy

Por Lapa, Constantin, Werner, Rudolf A, Bluemel, Christina, Lückerath, Katharina, Schirbel, Andreas, Strate, Alexander, Buck, Andreas K, Herrmann, Ken
Publicado no EJNMMI Res (2014)

The impact of (177)Lu-octreotide therapy on (99m)Tc-MAG3 clearance is not predictive for late nephropathy

Por Werner, Rudolf A., Beykan, Seval, Higuchi, Takahiro, Lückerath, Katharina, Weich, Alexander, Scheurlen, Michael, Bluemel, Christina, Herrmann, Ken, Buck, Andreas K., Lassmann, Michael, Lapa, Constantin, Hänscheid, Heribert
Publicado no Oncotarget (2016)

Impact of (68)Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy

Por Bluemel, Christina, Linke, Fraenze, Herrmann, Ken, Simunovic, Iva, Eiber, Matthias, Kestler, Christian, Buck, Andreas K., Schirbel, Andreas, Bley, Thorsten A., Wester, Hans-Juergen, Vergho, Daniel, Becker, Axel
Publicado no EJNMMI Res (2016)

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

Por Lapa, Constantin, Werner, Rudolf A, Bluemel, Christina, Lueckerath, Katharina, Muegge, Dirk O, Strate, Alexander, Haenscheid, Heribert, Schirbel, Andreas, Allen-Auerbach, Martin S, Bundschuh, Ralph A, Buck, Andreas K, Herrmann, Ken
Publicado no EJNMMI Res (2014)

(68)Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients

Por Fendler, Wolfgang Peter, Barrio, Martin, Spick, Claudio, Allen-Auerbach, Martin, Ambrosini, Valentina, Benz, Matthias, Bluemel, Christina, Grewal, Ravinder Kaur, Lapa, Constantin, Miederer, Matthias, Nicolas, Guillaume, Schuster, Tibor, Czernin, Johannes, Herrmann, Ken
Publicado no J Nucl Med (2017)

Biodistribution and Radiation Dosimetry for a Probe Targeting Prostate-Specific Membrane Antigen for Imaging and Therapy

Por Herrmann, Ken, Bluemel, Christina, Weineisen, Martina, Schottelius, Margret, Wester, Hans-Jürgen, Czernin, Johannes, Eberlein, Uta, Beykan, Seval, Lapa, Constantin, Riedmiller, Hubertus, Krebs, Markus, Kropf, Saskia, Schirbel, Andreas, Buck, Andreas K., Lassmann, Michael
Publicado no J Nucl Med (2015)

(68)Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative (18)F-Choline-PET/CT

Por Bluemel, Christina, Krebs, Markus, Polat, Bülent, Linke, Fränze, Eiber, Matthias, Samnick, Samuel, Lapa, Constantin, Lassmann, Michael, Riedmiller, Hubertus, Czernin, Johannes, Rubello, Domenico, Bley, Thorsten, Kropf, Saskia, Wester, Hans-Juergen, Buck, Andreas K., Herrmann, Ken
Publicado no Clin Nucl Med (2016)